Investigation of Adherence to DASH Diet Components and Reduction of Heart Failure Risk in Adults: A Case-control Study

Overview

Journal ARYA Atheroscler

Date 2024 Dec 24

PMID 39717422

Authors

Abbas Abbasi

Davood Shafie

Reza Heidari Moghaddam

Masoumeh Sadeghi

Seyyed Morteza Safavi

Affiliations

Soon will be listed here.

Abstract

Background: Heart failure (HF), or congestive Heart failure (CHF), is a heart disorder with a number of symptoms caused by the heart's inability to pump blood. Our aim in conducting this study is to investigate the adherence to dietary approaches to stop hypertension (DASH) diet components and the risk of HF in Iranian adult women and men.

Methods: In this hospital-based, case-control study, we included 340 participants (194 men and 146 women) aged 30-70 years who were recently (less than 6 months) diagnosed with HF. In this study, there were 169 participants in the control group and 171 participants in the case group. A semi-quantitative food frequency questionnaire (FFQ) with 148 items was used to assess food intake. Multiple logistic regression statistical tests were used to evaluate the relationship between DASH score and HF.

Results: After adjusting for confounding variables, the data showed that adherence to the DASH diet was associated with a reduced risk of HF. Our data show that a significant relationship was found between the consumption of fruits (OR: 0.62; 95% CI: 0.53-0.68), vegetables (OR: 0.53; 95% CI: 0.28-0.81), legumes and nuts (OR: 0.75; 95% CI: 0.65-0.68), and heart failure, but no significant relationship was found with the other components of the DASH diet and heart failure.

Conclusion: Findings suggest that there is an inverse relationship between adherence to the DASH-style diet and the likelihood of HF, and adherence to some components of the DASH diet was also effective in reducing the risk of HF. To obtain more complete results, it is necessary to conduct cohort studies and randomized clinical trials.

References

Savarese G, Lund L . Global Public Health Burden of Heart Failure. Card Fail Rev. 2017; 3(1):7-11. PMC: 5494150. DOI: 10.15420/cfr.2016:25:2. View

Pirouzeh R, Heidarzadeh-Esfahani N, Morvaridzadeh M, Izadi A, Yosaee S, Potter E . Effect of DASH diet on oxidative stress parameters: A systematic review and meta-analysis of randomized clinical trials. Diabetes Metab Syndr. 2021; 14(6):2131-2138. DOI: 10.1016/j.dsx.2020.10.031. View

Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Takeshita A . Characteristics and outcomes of patients with heart failure in general practices and hospitals. Circ J. 2007; 71(4):449-54. DOI: 10.1253/circj.71.449. View

Campbell A . DASH Eating Plan: An Eating Pattern for Diabetes Management. Diabetes Spectr. 2017; 30(2):76-81. PMC: 5439361. DOI: 10.2337/ds16-0084. View

Rodriguez-Lopez C, Gonzalez-Torres M, Aguilar-Salinas C, Najera-Medina O . DASH Diet as a Proposal for Improvement in Cellular Immunity and Its Association with Metabolic Parameters in Persons with Overweight and Obesity. Nutrients. 2021; 13(10). PMC: 8539000. DOI: 10.3390/nu13103540. View

Mozaffarian D, Appel L, Van Horn L . Components of a cardioprotective diet: new insights. Circulation. 2011; 123(24):2870-91. PMC: 6261290. DOI: 10.1161/CIRCULATIONAHA.110.968735. View

Panahi M, Papanikolaou A, Torabi A, Zhang J, Khan H, Vazir A . Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition. Cardiovasc Res. 2018; 114(11):1445-1461. PMC: 6106100. DOI: 10.1093/cvr/cvy145. View

Mohseni R, Mohseni F, Alizadeh S, Abbasi S . The Association of Dietary Approaches to Stop Hypertension (DASH) Diet with the Risk of Colorectal Cancer: A Meta-Analysis of Observational Studies. Nutr Cancer. 2019; 72(5):778-790. DOI: 10.1080/01635581.2019.1651880. View

Hirata K, Hyodo E, Hozumi T, Kita R, Hirose M, Sakanoue Y . Usefulness of a combination of systolic function by left ventricular ejection fraction and diastolic function by E/E' to predict prognosis in patients with heart failure. Am J Cardiol. 2009; 103(9):1275-9. DOI: 10.1016/j.amjcard.2009.01.024. View

10.

Farhadnejad H, Emamat H, Teymoori F, Tangestani H, Hekmatdoost A, Mirmiran P . Role of Dietary Approaches to Stop Hypertension Diet in Risk of Metabolic Syndrome: Evidence from Observational and Interventional Studies. Int J Prev Med. 2021; 12:24. PMC: 8218795. DOI: 10.4103/ijpvm.IJPVM_108_20. View

11.

Levitan E, Wolk A, Mittleman M . Consistency with the DASH diet and incidence of heart failure. Arch Intern Med. 2009; 169(9):851-7. PMC: 2682222. DOI: 10.1001/archinternmed.2009.56. View

12.

Peairs A, Shah A, Summer S, Hess M, Couch S . Effects of the dietary approaches to stop hypertension (DASH) diet on glucose variability in youth with Type 1 diabetes. Diabetes Manag (Lond). 2018; 7(5):383-391. PMC: 5763547. View

13.

Mahdavi A, Mohammadi H, Foshati S, Shokri-Mashhadi N, Clark C, Moafi A . Effects of the dietary approach to stop hypertension (DASH) diet on blood pressure, blood glucose, and lipid profile in adolescents with hemophilia: A randomized clinical trial. Food Sci Nutr. 2021; 9(1):145-153. PMC: 7802541. DOI: 10.1002/fsn3.1972. View

14.

Vanreusel I, Taeymans J, Van Craenenbroeck E, Segers V, Van Berendoncks A, Briede J . Elevated oxidative stress in patients with congenital heart disease and the effect of cyanosis: a meta-analysis. Free Radic Res. 2023; 57(6-12):470-486. DOI: 10.1080/10715762.2023.2284639. View

15.

Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F . Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 2012; 108(6):1109-17. DOI: 10.1017/S0007114511006313. View

16.

Al Zenki S, Al Omirah H, Al Hooti S, Al Hamad N, Jackson R, Rao A . High prevalence of metabolic syndrome among Kuwaiti adults--a wake-up call for public health intervention. Int J Environ Res Public Health. 2012; 9(5):1984-96. PMC: 3386600. DOI: 10.3390/ijerph9051984. View

17.

Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin M, Badoual T . N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation. 2004; 110(14):2003-9. DOI: 10.1161/01.CIR.0000143630.14515.7C. View

18.

Fung T, Chiuve S, McCullough M, Rexrode K, Logroscino G, Hu F . Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008; 168(7):713-20. DOI: 10.1001/archinte.168.7.713. View

19.

Szekely Y, Arbel Y . A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?. Cardiol Ther. 2018; 7(1):25-44. PMC: 5986669. DOI: 10.1007/s40119-018-0104-3. View

20.

Perez A, Grodin J, Chaikijurajai T, Wu Y, Hernandez A, Butler J . Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy. J Card Fail. 2021; 27(6):670-676. DOI: 10.1016/j.cardfail.2021.01.006. View